Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1
Scandinavian Journal of Immunology · 2025-04 · 101 (4)
DOI: 10.1111/sji.70021 ↗Kurz gefasst
Fachartikel in der Zeitschrift Scandinavian Journal of Immunology, 2025-04. Verfasst von Isil Kucuka und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical Science, Department of Medicine, University of Bergen, Bergen, Norway. Hauptthemen laut MEDLINE: Polyendocrinopathies, Autoimmune, B-Lymphocytes, Killer Cells, Natural, T-Lymphocytes, Regulatory. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 58 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Novo Nordisk Fonden, Norges Forskningsråd, Helse Vest.
Abstract (Originalsprache)
Autoimmune polyendocrine syndrome Type‐1 (APS‐1) is a rare, but severe organ‐specific autoimmune disease caused by mutations in the autoimmune regulator (AIRE) gene. Lack of AIRE causes autoreactive T cells to escape negative selection and alters the T regulatory cell subset. However, little is known about how the immune cell subsets vary across the lifespan in APS‐1. Here we analysed the peripheral distribution of 13 immune cell subsets along the lifespan using epigenetic quantification. We found the largest discrepancy in immune cells to appear early in APS‐1 patients' lives, coinciding with the time point they obtained most of their clinical symptoms. We further revealed longitudinal changes in cell compositions both within the adaptive and the innate arms of the immune system. We found that cell frequencies of B cells, T‐cell subgroups, nonclassical monocytes, and Natural Killer cells to be reduced in young APS‐1 patients. We also found B‐cell frequencies to decrease with ageing in both patients and healthy controls. Our results suggest that Tregs, follicular helper T, and natural killer cells have opposing trends of cell frequencies during life, indicating the importance of considering the age profiles of cohorts which could otherwise lead to conflicting conclusions.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical Science, Department of Medicine, University of Bergen, Bergen, Norway.
- Department of Medicine, Haukeland University Hospital, Bergen, Norway.
- Health Research Sogn Og Fjordane, Førde Hospital Trust, Førde, Norway.
ORCID-Profile: Bergithe E Oftedal
Förderung
- Novo Nordisk Fonden
- Norges Forskningsråd
- Helse Vest
Zitieren
APA
Kucuka, I., Iraji, D., Braun, S., Breivik, L., Wolff, A. S. B., Husebye, E. S., & Oftedal, B. E. (2025). Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1. Scandinavian Journal of Immunology, 101(4). https://doi.org/10.1111/sji.70021
Vancouver
Kucuka I, Iraji D, Braun S, Breivik L, Wolff ASB, Husebye ES, et al. Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1. Scandinavian Journal of Immunology. 2025;101(4). doi:10.1111/sji.70021
BibTeX
@article{Kucuka2025,
author = {Kucuka, Isil and Iraji, Dorsa and Braun, Sarah and Breivik, Lars and Wolff, Anette S B and Husebye, Eystein S and Oftedal, Bergithe E},
title = {Longitudinal Immune Profiling in Autoimmune Polyendocrine Syndrome Type 1},
journal = {Scandinavian Journal of Immunology},
year = {2025},
volume = {101},
number = {4},
doi = {10.1111/sji.70021}
}
EUVIMED